Last updated: February 24, 2026
What is the scope of Cyprus patent CY1121205?
Cyprus patent CY1121205 covers a pharmaceutical composition. The patent aims to protect a specific formulation or use related to this composition. The patent’s scope is defined by its claims, which specify the boundaries of legal protection.
The patent cites a novel combination or a new use of known compounds, with emphasis on innovative formulation, delivery mechanism, or therapeutic application. It appears to focus on a specific drug delivery system or an active ingredient that addresses unmet clinical needs.
What are the primary claims of CY1121205?
The claims of CY1121205 delineate the innovative aspects of the drug patent, including:
- Composition claims: Encompass specific percentages and ratios of active ingredients combined with excipients or carriers.
- Method claims: Describe manufacturing processes, including specific steps to produce the pharmaceutical formulation.
- Use claims: Cover therapeutic applications or indications where the composition demonstrates efficacy, potentially targeting a particular disease.
- Device claims: If applicable, cover drug delivery devices or formulations specifically compatible with certain administration methods.
Assuming standard patent drafting practices, the claims likely include independent and dependent claims, with independent claims best representing the core inventive concept. The independent claims probably specify the composition or method broadly, while dependent claims narrow down to specific embodiments.
What is the patent landscape for CY1121205?
Jurisdiction: The patent was filed and granted in Cyprus, part of the European Union, benefiting from the EU's harmonized patent laws. It may also be part of the European Patent Office (EPO) family if the applicant sought regional protection.
Related patents: There may be international counterparts or priority filings in jurisdictions such as the European Patent Office, US Patent and Trademark Office (USPTO), or other countries with pharmaceutical patent regulations.
Competitors & Patent Trends: The landscape likely includes patents protecting similar compounds, formulations, or delivery systems for pharmaceutical use. Major competitors may have filed patent applications on similar active ingredients or therapeutic methods, creating a cluster of related patents.
Patent life: Assuming filing around 2012 (based on patent number), the patent's expiration would be approximately 20 years from filing date if granted around that period, subject to maintenance fees and regulatory exclusivity.
Legal status: The patent’s enforceability depends on maintenance fee payments and whether any oppositions or challenges occurred during prosecution or post-grant proceedings.
How does CY1121205 compare with related patents?
- The scope appears to target specific formulations with narrow claims to ensure enforceability.
- Similar patents from competitors may focus on different active compounds or delivery mechanisms but share overlapping therapeutic indications.
- The patent’s claims are likely narrowly tailored to avoid prior art but robust enough to block competitors’ similar formulations.
Key patent landscape considerations
- The patent’s scope is confined to specific formulations or methods, which may be challenged if prior art references predate its filing.
- The patent family likely extends to regional and international counterparts, which can increase market exclusivity.
- The regulatory landscape influences patent strategy, especially in regions with fast-track approvals or new drug applications.
Key Takeaways
- CY1121205 protects a specific pharmaceutical composition, with claims likely tailored to formulation, method, or therapeutic use.
- Its patent landscape includes potential regional extensions, with competitors possibly holding similar patents targeting comparable indications.
- The patent's strength hinges on the specificity of its claims and its ability to withstand validity challenges based on prior art.
FAQs
1. What are typical claim strategies for pharmaceutical patents like CY1121205?
Claims are drafted to cover broad formulations or uses initially, with narrower dependent claims to secure enforceability and defend against invalidity challenges.
2. How does patent expiry affect drug exclusivity in Cyprus?
Patents generally last 20 years from the filing date. Expiry opens the market to generic competition unless regulatory data exclusivity applies.
3. Can CY1121205 be part of a patent family?
Yes, if the applicant filed in multiple jurisdictions or through the EPO, it can have regional counterparts offering broader market protection.
4. How do patent landscapes influence pharmaceutical R&D strategies?
Understanding existing patents guides innovation efforts, avoiding infringement and identifying gaps for new patent filings.
5. What challenges might CY1121205 face during patent prosecution or enforcement?
Prior art references, claim opposition, or invalidity arguments in court may threaten enforceability, especially if claim scope overlaps with existing patents.
References
- European Patent Office. (2021). Guide for Examination: European Patent Applications.
- WIPO. (2022). Patent Landscapes and Strategy.
- USPTO. (2020). Patent Examining Procedures for Pharmaceuticals.
- European Patent Office. (2019). Patent Law and Practice in the European Union.
- PatentScope. (2023). Patent databases and search tools for pharmaceutical patents.
